$222 Million is the total value of Ghost Tree Capital, LLC's 74 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 63.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Sell | Allergan PLC | $10,193,000 | -25.4% | 37,500 | -16.7% | 4.59% | +3.7% |
| NUVA | Sell | NUVASIVE INC | $8,439,000 | -24.2% | 175,000 | -25.5% | 3.80% | +5.3% |
| FLML | Sell | FLAMEL TECHNOLOGIES SAsponsored adr | $5,709,000 | -53.1% | 350,000 | -39.1% | 2.57% | -34.9% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $4,132,000 | -39.2% | 525,000 | -30.0% | 1.86% | -15.5% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $3,217,000 | -66.8% | 7,000 | -65.0% | 1.45% | -53.9% |
| QURE | Sell | UNIQURE B.V. | $3,068,000 | -38.6% | 150,000 | -18.9% | 1.38% | -14.7% |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $2,830,000 | -33.9% | 175,000 | -33.4% | 1.27% | -8.1% |
| VTAE | Sell | VITAE PHARMACEUTICALS INC | $2,753,000 | -33.9% | 250,000 | -13.6% | 1.24% | -8.2% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $2,741,000 | -70.2% | 30,000 | -60.0% | 1.23% | -58.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,188,000 | -62.6% | 55,000 | -55.1% | 0.98% | -48.0% |
| CLLS | Sell | CELLECTIS - ADRsponsored ads | $1,977,000 | -56.2% | 75,000 | -40.0% | 0.89% | -39.1% |
| EPZM | Sell | EPIZYME INC | $1,929,000 | -67.8% | 150,000 | -40.0% | 0.87% | -55.3% |
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $1,728,000 | -46.2% | 300,000 | -14.3% | 0.78% | -25.2% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $1,727,000 | -58.9% | 40,800 | -29.0% | 0.78% | -42.9% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $1,507,000 | -59.3% | 220,000 | -18.5% | 0.68% | -43.5% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $1,100,000 | -57.1% | 150,000 | -40.0% | 0.50% | -40.4% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $1,066,000 | -86.2% | 25,000 | -85.3% | 0.48% | -80.9% |
| BDSI | Sell | BIODELIVERY SCIENCES INTERNATIONAL INC | $556,000 | -76.7% | 100,000 | -66.7% | 0.25% | -67.7% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $490,000 | -76.0% | 6,500 | -62.9% | 0.22% | -66.6% |
| UNIS | Sell | UNILIFE CORP NEW | $343,000 | -64.6% | 350,000 | -22.2% | 0.15% | -51.0% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $237,000 | -93.7% | 292,939 | -76.6% | 0.11% | -91.2% |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -15,000 | -100.0% | -0.08% | – |
| NEOT | Exit | NEOTHETICS INC | $0 | – | -43,000 | -100.0% | -0.12% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -37,500 | -100.0% | -0.14% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -15,000 | -100.0% | -0.14% | – |
| XOMA | Exit | XOMA CORP DEL | $0 | – | -125,000 | -100.0% | -0.16% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -93,500 | -100.0% | -0.21% | – |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.25% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL INcall | $0 | – | -106,200 | -100.0% | -0.27% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -76,850 | -100.0% | -0.46% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -100,000 | -100.0% | -0.49% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -25,000 | -100.0% | -0.55% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -31,700 | -100.0% | -0.75% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES INcall | $0 | – | -150,000 | -100.0% | -0.79% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -135,000 | -100.0% | -0.89% | – |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -400,000 | -100.0% | -1.02% | – |
| KMPH | Exit | KEMPHARM INC | $0 | – | -175,000 | -100.0% | -1.04% | – |
| RMTI | Exit | ROCKWELL MED INCcall | $0 | – | -200,000 | -100.0% | -1.04% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -20,000 | -100.0% | -1.06% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -175,000 | -100.0% | -1.09% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -150,000 | -100.0% | -1.28% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -1.37% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -1.44% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.56% | – |
| GI | Exit | ENDOCHOICE HLDGS INC | $0 | – | -300,000 | -100.0% | -1.59% | – |
| ANAC | Exit | ANACOR PHARMACEUTICALS INC | $0 | – | -65,000 | -100.0% | -1.63% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -40,000 | -100.0% | -1.65% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -65,000 | -100.0% | -1.68% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -1.72% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -37,500 | -100.0% | -1.97% | – |
| CPHD | Exit | CEPHEID | $0 | – | -100,000 | -100.0% | -1.98% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -75,000 | -100.0% | -1.99% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -2.40% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -2.93% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -120,000 | -100.0% | -3.10% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -3.50% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -30,000 | -100.0% | -3.93% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.